Here, we define a mechanism of non-genetic drug adaptation in melanoma whereby adaptive mitochondrial metabolism is regulated at the level of mRNA export and translation, and we identify the RNA processing kinase UHMK1 as a central factor in this process. Here, UHMK1 is linked to melanoma.